The effect of Hoffa*s fat pad resection in total knee arthroplasty on functionality and pain: a double blind, randomized clinical trial

The effect of Hoffa*s fat pad resection in total knee arthroplasty on functionality and pain: a double blind, randomized clinical trial - HOPE-study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON44041

Enrollment

Registered

2012-10-30

Start date

2013-04-29

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anterior knee pain Hoffa's disease

Interventions

One group will undergo Hoffa*s fat pad resection and one group will not, during implantation of a total knee prosthesis.

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Patients who are planned to undergo a primary total knee arthroplasty in the Joint-Care program of the Medical Centre Alkmaar. - Age between 30 and 80 years - Patients with ASA Physical Status I & II

Exclusion criteria

Exclusion criteria: - Patients with another prosthesis in either one of the lower extremities - Patients diagnosed with rheumatoid arthritis - Patients who suffer from insulin dependant diabetes - Patients who lack understanding of the Dutch language - Patients who are treated for or diagnosed with neurological or muscle disorders which make assessment of pain and gait not possible

Design outcomes

Primary

Measure	Time frame
Range of motion at 6 weeks and 3 and 12 months. Gait parameters and preferred walking speed at 3 and 12 months	—

Secondary

Measure	Time frame
VAS anterior knee pain score 1 week diary at 6 weeks and 3 and 12 months KOOS and Kujala score at 6 weeks and 3 and 12 months Complications and adverse events	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)